uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Beqvez (previously Durveqtix)
Withdrawn
Human
Details
EMA number
EMEA/H/C/004774
ATC code
-
Authorisation
24 July 2024
Withdrawn
15 May 2025
Revision
3
EMA page
Therapeutic indication
Not specified
MeSH:
Hemophilia B
Group:
Antihemorrhagics
Special characteristics
Additional monitoring
Conditional authorisation
Active substances
fidanacogene elaparvovec
Marketing Authorisation Holder
Pfizer Europe MA EEIG
MAH
Timeline
Filter by authority:
EMA
Beqvez (previously Durveqtix) withdrawn
15 May 2025
withdrawn
regulatory
Beqvez (previously Durveqtix) authorised
24 Jul 2024
authorised
regulatory
Beqvez (previously Durveqtix) | uMedical